Back to calendar
Ultragenyx Pharmaceutical Inc. (RARE) Earnings
RARE reports earnings on Tuesday, August 4, 2026
earnings report
August 4, 2026 · After Market Close
Q2 2026
Est. EPS: $-1.21
Actual EPS: $-1.84
EPS surprise: -23.67%
Company overview
Market Cap$2.5B
PriceUSD 25.00
EPS (TTM)-6.11
52-week high39.89
52-week low18.29
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees1,371